Displaying drugs 2501 - 2525 of 3145 in total
Kifunensine
Experimental
4-Methylidene-5-One
Experimental
N-Succinyl Phenylglycine
Experimental
Chromophore (Met-Tyr-Gly)
Experimental
(S)-Aspartimide
Experimental
N~2~-Succinylornithine
Experimental
Degraded Cephaloridine
Experimental
Allantoate
Experimental
Glyphosate
Experimental
Seletracetam
Seletracetam is a pyrrolidone derivative and with a structural similarity to newer generation antiepileptic drug levetiracetam. It binds to the same target as levetiracetam but with higher affinity and has shown potent seizure suppression in models of acquired and genetic epilepsy with high CNS tolerability. It is predicted to have...
Investigational
Opaviraline
Experimental
N-(3-MERCAPTOPROPANOYL)-D-ALANINE
Experimental
4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE
Experimental
FG-2216
A orally active prolyl-hydroxylase inhibitor which can stabilize hypoxia-inducible transcription factor independent of oxygen availability.
Investigational
Marizomib
Marizomib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Malignant Glioma, among others.
Investigational
Etiracetam
Etiracetam is under investigation in clinical trial NCT01137110 (Comparison of Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After Subarachnoid Hemorrhage (SAH)).
Investigational
Displaying drugs 2501 - 2525 of 3145 in total